Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Journal of Virology|January 13, 2012
Varicella-Zoster virus ORF12 protein triggers phosphorylation of ERK1/2 and inhibits apoptosisXueqiao Liu, Qingxue Li, Kennichi Dowdell, et al.Plos Pathogens|September 3, 2024
A nonhuman primate model for genital herpes simplex virus 2 infection that results in vaginal vesicular lesions, virus shedding, and seroconversionKening Wang, Tristan Jordan, Kennichi Dowdell, et al.Journal of Clinical Immunology|May 8, 2015
Late-onset severe chronic active EBV in a patient for five years with mutations in STXBP2 (MUNC18-2) and PRF1 (perforin 1)Jeffrey I Cohen, Julie E Niemela, Jennifer L Stoddard, et al.Frontiers in Immunology|September 12, 2019
Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell KinaseMatthew K Howe, Kennichi Dowdell, Amitava Roy, et al.The Journal of Clinical Investigation|June 6, 2017
Glutamine supplementation suppresses herpes simplex virus reactivationKening Wang, Yo Hoshino, Kennichi Dowdell, et al.Leukemia & Lymphoma|October 1, 2016
Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the bloodAmber Shatzer, Mir A Ali, Mayra Chavez, et al.Immunity|March 13, 2024
Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cellsWei Bu, Ashish Kumar, Nathan L Board, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2010
Cutting edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription factor eomesoderminIchiko Kinjyo, Scott M Gordon, Andrew M Intlekofer, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2016
Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated CancersJeffrey I Cohen, Lesia Dropulic, Amy P Hsu, et al.The Lancet. Haematology|April 3, 2023
Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trialChristopher Melani, Kennichi Dowdell, Stefania Pittaluga, et al.Pageof 2